BRPI1007728A2 - uso de extratos de folhas de oliveira,composição farmacêutica e método de tratamento e/ou prevenção de feridas ou úlceras - Google Patents

uso de extratos de folhas de oliveira,composição farmacêutica e método de tratamento e/ou prevenção de feridas ou úlceras

Info

Publication number
BRPI1007728A2
BRPI1007728A2 BRPI1007728A BRPI1007728A BRPI1007728A2 BR PI1007728 A2 BRPI1007728 A2 BR PI1007728A2 BR PI1007728 A BRPI1007728 A BR PI1007728A BR PI1007728 A BRPI1007728 A BR PI1007728A BR PI1007728 A2 BRPI1007728 A2 BR PI1007728A2
Authority
BR
Brazil
Prior art keywords
ulcers
treating
pharmaceutical composition
olive leaf
leaf extracts
Prior art date
Application number
BRPI1007728A
Other languages
English (en)
Inventor
Antonio Casado Diaz
José Manuel Quesada Gómez
Maria Dolores Luque De Castro
Raquel Maria Santiago Mora
Original Assignee
Sanidad Y Residencias 21 S A
Servicio Andaluz De Salud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanidad Y Residencias 21 S A, Servicio Andaluz De Salud filed Critical Sanidad Y Residencias 21 S A
Publication of BRPI1007728A2 publication Critical patent/BRPI1007728A2/pt
Publication of BRPI1007728A8 publication Critical patent/BRPI1007728A8/pt
Publication of BRPI1007728B1 publication Critical patent/BRPI1007728B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

abstract not avaible
BRPI1007728-6A 2009-05-14 2010-05-14 uso de uma composição farmacêutica BRPI1007728B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200901296 2009-05-14
ES200901296A ES2349976B1 (es) 2009-05-14 2009-05-14 Utilizacion de extractos de hojas de olivo en una composicion farmaceutica para inducir angiogenesis y vasculogenesis.
PCT/ES2010/070327 WO2010130869A1 (es) 2009-05-14 2010-05-14 Utilización de extractos de hojas de olivo en una composición farmacéutica para inducir angiogénesis y vasculogénesis

Publications (3)

Publication Number Publication Date
BRPI1007728A2 true BRPI1007728A2 (pt) 2016-12-27
BRPI1007728A8 BRPI1007728A8 (pt) 2018-06-12
BRPI1007728B1 BRPI1007728B1 (pt) 2021-06-08

Family

ID=43084660

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007728-6A BRPI1007728B1 (pt) 2009-05-14 2010-05-14 uso de uma composição farmacêutica

Country Status (14)

Country Link
US (1) US20120141435A1 (pt)
EP (1) EP2431046B1 (pt)
BR (1) BRPI1007728B1 (pt)
CY (1) CY1116447T1 (pt)
DK (1) DK2431046T3 (pt)
ES (3) ES2349976B1 (pt)
HR (1) HRP20150455T1 (pt)
LT (1) LT2570124T (pt)
MX (1) MX2011011970A (pt)
PL (1) PL2431046T3 (pt)
PT (1) PT2431046E (pt)
RS (1) RS55672B1 (pt)
SI (1) SI2431046T1 (pt)
WO (1) WO2010130869A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011141611A1 (es) * 2010-05-14 2011-11-17 Sanidad Y Residencias 21, S.A., Composiciones de oleuropeína para cicatrización de heridas y úlceras en ancianos y/o diabéticos
ES2395539B1 (es) * 2011-06-16 2014-01-20 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Uso del aceite de oliva en la prevención y el tratamiento de las enfermedades que cursan con un proceso isquémico
CN116920069B (zh) * 2023-07-06 2024-05-17 廊坊康宝汇泰生物技术有限公司 一种中药提取液及其在促进脐带干细胞分泌vegf中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4139196A (en) * 1994-11-07 1996-05-31 William R. Fredrickson Method and composition for antiviral therapy
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6455070B1 (en) * 2001-02-15 2002-09-24 East Park Research, Inc. Composition for treating symptoms of influenza
BR0209922A (pt) * 2001-05-23 2004-07-27 Hamdi K Hamdi Método para tratar uma condição médica que envolve a angiogênese em um paciente, para inibir a vascularização de células endoteliais, e para tratar câncer em um mamìfero
WO2004076680A2 (en) * 2003-02-25 2004-09-10 D Amelio Frank Process and composition for inhibiting growth of microorganisms
WO2004093569A1 (en) * 2003-04-21 2004-11-04 Osman Fathi Osman Topical composition on the basis of honey
EP1481669A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
JP2005245346A (ja) * 2004-03-05 2005-09-15 Kazuo Kagami 複合健康補助食品
NZ532666A (en) 2004-04-30 2008-03-28 Ind Res Ltd A method of promoting angiogenesis, or treating a disease or disorder where it is desirable to promote angiogenesis, comprising administering a therapeutically effective amount of an angiogenesis promoting extract of the skin of a citrus fruit to a non-human animal
DE202005007222U1 (de) * 2005-05-06 2005-07-14 Oliveda Network S.L. Zubereitung auf Basis von flüssigem Olivenblattextrakt und Glycerin
US8758838B2 (en) * 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
ES2274721B1 (es) * 2005-11-03 2008-06-01 Laboratorios Belmac, S.A. Nuevo agente terapeutico para el tratamiento de una condicion asociada a la enfermedad vascular periferica.
US20070292463A1 (en) * 2005-12-22 2007-12-20 Donald Spector Compositions and methods comprising energizable particles for health use
JP2008081425A (ja) * 2006-09-27 2008-04-10 Shiseido Co Ltd 内臓脂肪蓄積抑制剤
JP2008273938A (ja) * 2007-03-30 2008-11-13 Shiseido Co Ltd アディポネクチン産生促進剤
CA2629652A1 (en) * 2007-04-24 2008-10-24 Yaojiong Wu Compositions for preventing or treating skin defects and methods of use thereof
WO2010070183A1 (es) * 2008-12-18 2010-06-24 Sanidad Y Residencias 21, S.A.U. Composición farmacéutica que comprende oleuropeina para utilización en la inducción de angiogénesis y vasculogénesis

Also Published As

Publication number Publication date
ES2613950T3 (es) 2017-05-29
HRP20150455T1 (hr) 2015-08-14
ES2535758T3 (es) 2015-05-14
EP2431046B1 (en) 2015-02-18
ES2349976A1 (es) 2011-01-13
US20120141435A1 (en) 2012-06-07
WO2010130869A1 (es) 2010-11-18
SI2431046T1 (sl) 2015-07-31
LT2570124T (lt) 2017-02-27
EP2431046A1 (en) 2012-03-21
DK2431046T3 (en) 2015-05-11
PL2431046T3 (pl) 2015-07-31
ES2349976B1 (es) 2011-11-10
EP2431046A4 (en) 2013-07-31
CY1116447T1 (el) 2017-02-08
BRPI1007728B1 (pt) 2021-06-08
MX2011011970A (es) 2012-07-17
PT2431046E (pt) 2015-05-28
BRPI1007728A8 (pt) 2018-06-12
RS55672B1 (sr) 2017-06-30

Similar Documents

Publication Publication Date Title
EA201291031A1 (ru) Способ лечения ожирения с применением антиоксидантных модуляторов воспаления
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
CO6640289A2 (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
BR112015026307A2 (pt) heterociclo bicíclicos como inibidores de fgfr
SMT201600182B (it) Ligandi sigma per l'uso nella prevenzione e/o nel trattamento del dolore post-operatorio
EP4249001A3 (en) Topical gels
BR112013015855A2 (pt) composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
CR11731A (es) Composiciones y procedimientos para su preparación y uso
BR112012007747A2 (pt) Compostos heterocíclicos úteis como inibidores de pdk1, sua composição farmacêutica e seus usos
BR112013016535A2 (pt) extratos vegetais para o tratamento e prevenção de infecções
EA201270567A1 (ru) Противомикробные соединения и способы их получения и применения
BRPI0908951A2 (pt) compostos de minociclina e método de uso dos mesmos
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
BR112013001297A2 (pt) composições farmacêuticas e respectivo uso e método de tratamento de doença ou condição respiratória
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BR112013018365A2 (pt) "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica"
BR112013015877A2 (pt) composto, uso de um composto, métodos de prevenção. tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
EA201290808A1 (ru) Замещенные конденсированные производные имидазола, фармацевтические композиции и способы их применения
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BR112014000795A2 (pt) uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias
EA201500913A1 (ru) Противомикробные соединения и способы их получения и применения
BR112012015386B8 (pt) composição oftálmica tópica
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
BRPI1008103A2 (pt) " peptídeo de cadeia curta isolado, composição farmacêutica, compostos, método de evitar ou tratar doenças, medicamento para tratar/ reduzir condições médicas e uso dos compostos "

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: SANIDAD Y RESIDENCIAS 21, S.A. (ES) , SERVICIO ANDALUZ DE SALUD (ES)

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO 018120024314 DE 04/07/2012, E NECESSARIO E NECESSARIO APRESENTAR NOTORIZACAO E LEGALIZACAO CONSULAR OU APOSTILAMENTO, SEGUNDO A CONVENCAO DE HAIA DO DOCUMENTO DE CESSAO APRESENTADO.

Owner name: SANIDAD Y RESIDENCIAS 21, S.A. (ES) , SERVICIO AND

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: SANIDAD Y RESIDENCIAS 21, S.A. (ES) ; SERVICIO AND

B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2475 DE 12/06/2018 POR TER SIDO INDEVIDA.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/05/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25A Requested transfer of rights approved

Owner name: SERVICIO ANDALUZ DE SALUD (ES) ; QUESPER RANDD, S.L., (ES) ; SANYRES SUR SL (ES)

B25A Requested transfer of rights approved

Owner name: SERVICIO ANDALUZ DE SALUD (ES) ; QUESPER RANDD, S.L., (ES) ; NOVENTURE S.L. (ES)